Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review Publisher Pubmed



Soleimani A1, 2 ; Soleimani Z3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Chamran Cardiovascular Medical and Research Center, Echocardiography department, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Perinatologist, Nephrology and Urology research center, Baqiyatallah University of Medical Sciences, Tehran, Iran
  4. 4. Fetal Health Research center, Hope Generation Foundation, Tehran, Iran

Source: Current Problems in Cardiology Published:2022


Abstract

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-COV2) infection is a rapid evolving pandemic with multiple peaks of outbreak and substantial mortality worldwide. It has been proposed that infants are more vulnerable to SARS-COV-2 infection. On the other hand, children with COVID-19 have generally milder disease compared to infected adults and more often presented with gastrointestinal symptoms compared to respiratory ones. Multisystem inflammatory syndrome in children (MIS-c) is an ominous demonstration of COVID-19 with cardiac involvement and mortality rate <2%. From cardiovascular point of view, wide spectrum of manifestations including subclinical myocardial injury, myocarditis, stress cardiomyopathies, cardiac arrhythmias, pulmonary thromboembolism and thrombus formation in cardiac chambers and vascular bed has been reported in COVID-19 disease. Congenital heart disease (CHD), assumed as the most prevalent form of congenital disease. Advances in medical and surgical treatments for CHD have led to more alive patients with underlying heart disease secondary to congenital defects. These group of pediatric patients are prone to heart failure, arrhythmia and embolic events. In this narrative review, we intended to evaluate the cardiovascular and pediatric presentations of COVID-19 as well as the manifestation and outcomes of SARS-CoV-2 infection on pediatric patients with CHD. © 2021 Elsevier Inc.
Other Related Docs
19. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
28. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
33. A Late Covid-19 Complication: Male Sexual Dysfunction, Prehospital and Disaster Medicine (2020)
38. Impact of Covid-19 Infection on Neonatal Birth Outcomes, Journal of Tropical Pediatrics (2021)
42. Case Report: Barotrauma in Covid-19 Case Series, American Journal of Tropical Medicine and Hygiene (2021)
43. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
49. Adrenal Insufficiency in Coronavirus Disease 2019: A Case Report, Journal of Medical Case Reports (2020)
50. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)